Kiromic Biopharma (NASDAQ: KRBP) reported Q3 2022 earnings per share (EPS) of -$22.50, up 87.5% year over year. Total Kiromic Biopharma earnings for the quarter were -$11.86 million. In the same quarter last year, Kiromic Biopharma's earnings per share (EPS) was -$12.00.
As of Q1 2023, Kiromic Biopharma's earnings has grown year over year. Kiromic Biopharma's earnings in the past year totalled -$38.30 million.
What is KRBP's earnings date?
Kiromic Biopharma's earnings date is Invalid Date. Add KRBP to your watchlist to be reminded of KRBP's next earnings announcement.
What was KRBP's revenue last quarter?
Kiromic Biopharma (NASDAQ: KRBP) reported Q3 2022 revenue of $0.00 up N/A year over year. In the same quarter last year, Kiromic Biopharma's revenue was $0.00.
What was KRBP's revenue growth in the past year?
As of Q1 2023, Kiromic Biopharma's revenue has grown null year over year. Kiromic Biopharma's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.